Sign up
Pharma Capital

Emerald Health Therapeutics 'on the cutting edge' of new cannabis market

Chris Wagner, chief executive of Emerald Health Therapeutics Inc (CVE:EMH, OTCQX:EMHTF), tells Proactive's Andrew Scott they're a licensed producer by Health Canada to grow, sell and produce cannabis across the country.

''We're ramping up for what will be the largest adult use market in the world ... on October 17 of this year there are regulations and laws in Canada which will change and it will allow adult use''.

''Right now we're selling and producing product for medical purposes only''.

''There are no companies like Emerald anywhere outside of Canada .. so if you  want to invest in companies that are on the cutting edge of this brand new market you need to look at Canadian companies''.

''We've been able to raise a tremendous amount of capital, put together a fantastic team, develop new products  and we're way ahead of everybody else on the planet''.

''If you want to be involved in a new industry ... this is the place to be''.


View full EMH profile View Profile
View All

© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.